Castle Biosciences Inc reports results for the quarter ended in September 30 - Earnings Summary

Castle Biosciences

05/11/2024 08:00

* Castle Biosciences Inc  CSTL.OQ  reported quarterly
adjusted
earnings of 8 cents​​ per share for the quarter ended September
30, higher than the same quarter last year, when the company
reported EPS of -26 cents.  The mean expectation of
nine analysts for the quarter was for a loss of 6 cents per
share. Wall Street expected results to range from -50 cents
to 19 cents per share.
    * Revenue rose 39.5% to $85.78 million from a year ago;
analysts
expected $79.84 million. 
    * Castle Biosciences Inc's reported EPS for the quarter was
8
cents​.
    * The company reported quarterly net income of $2.27
million.
    * Castle Biosciences Inc shares had risen by 18.0% this
quarter and gained 55.9% so far this year.

FORECAST CHANGES
    * The mean earnings estimate of analysts had risen by
about 77.7%
in the last three months.​ 
    * In the last 30 days, there have been no negative revisions
of
earnings estimates

RECOMMENDATIONS
    * The current average analyst rating on the shares is
"strong buy"
and the breakdown of recommendations is 9 "strong buy" or
"buy," no "hold" and no "sell" or "strong sell." 
    * The average consensus recommendation for the medical
equipment,
supplies & distribution peer group is also "strong buy"

Wall Street's median 12-month price target for Castle
Biosciences Inc is 39.00 
This summary was machine generated from LSEG data November 5 at
08:00 a.m. UTC. ​All figures in US dollars unless otherwise
stated. (For questions concerning the data in this report,
contact Estimates.Support@lseg.com. For any other questions or
feedback, contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Sep. 30 2024      -0.06          0.08           Beat
 Jun. 30 2024      -0.27          0.31           Beat
 Mar. 31 2024      -0.33          -0.09          Beat
 Dec. 31 2023      -0.54          -0.10          Beat